134 related articles for article (PubMed ID: 35772286)
1. Withaferin A, a polyfunctional pharmacophore that includes covalent engagement of IPO5, is an inhibitor of influenza A replication.
Patouret R; Barluenga S; Winssinger N
Bioorg Med Chem; 2022 Sep; 69():116883. PubMed ID: 35772286
[TBL] [Abstract][Full Text] [Related]
2. Evaluating anticancer properties of Withaferin A-a potent phytochemical.
Atteeq M
Front Pharmacol; 2022; 13():975320. PubMed ID: 36339589
[TBL] [Abstract][Full Text] [Related]
3. Withaferin A and its potential role in glioblastoma (GBM).
Dhami J; Chang E; Gambhir SS
J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
6. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
[TBL] [Abstract][Full Text] [Related]
7.
Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
[TBL] [Abstract][Full Text] [Related]
8. Interaction Studies of Withania Somnifera's Key Metabolite Withaferin A with Different Receptors Assoociated with Cardiovascular Disease.
Ravindran R; Sharma N; Roy S; Thakur AR; Ganesh S; Kumar S; Devi J; Rajkumar J
Curr Comput Aided Drug Des; 2015; 11(3):212-21. PubMed ID: 26548552
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.
Vyas AR; Singh SV
AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237
[TBL] [Abstract][Full Text] [Related]
10. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
[TBL] [Abstract][Full Text] [Related]
11. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
12. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study.
Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X
Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548
[TBL] [Abstract][Full Text] [Related]
13. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.
Sivasankarapillai VS; Madhu Kumar Nair R; Rahdar A; Bungau S; Zaha DC; Aleya L; Tit DM
Environ Sci Pollut Res Int; 2020 Jul; 27(21):26025-26035. PubMed ID: 32405942
[TBL] [Abstract][Full Text] [Related]
14. Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic Insights.
Xia Y; Yan M; Wang P; Hamada K; Yan N; Hao H; Gonzalez FJ; Yan T
Drug Metab Dispos; 2022 May; 50(5):685-693. PubMed ID: 34903587
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
16. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
17. On the action and mechanism of withaferin-A from Withania somnifera, a novel and potent melanin dispersing agent in frog melanophores.
Ali SA; Meitei KV
J Recept Signal Transduct Res; 2011 Oct; 31(5):359-66. PubMed ID: 21848494
[TBL] [Abstract][Full Text] [Related]
18. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug.
Hassannia B; Logie E; Vandenabeele P; Vanden Berghe T; Vanden Berghe W
Biochem Pharmacol; 2020 Mar; 173():113602. PubMed ID: 31404528
[TBL] [Abstract][Full Text] [Related]
19. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
20. Withania somnifera chemotypes NMITLI 101R, NMITLI 118R, NMITLI 128R and withaferin A protect Mastomys coucha from Brugia malayi infection.
Kushwaha S; Soni VK; Singh PK; Bano N; Kumar A; Sangwan RS; Misra-Bhattacharya S
Parasite Immunol; 2012 Apr; 34(4):199-209. PubMed ID: 22394222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]